Blog Posts (76)
June 14, 2016
In a healthy consumer market, people compare the price and quality of goods inside whether it’s worth paying extra money to get the best possible products. In healthcare, it’s often almost impossible to figure out what things cost. And when … Continue reading →
The post Need More Evidence the U.S. Healthcare Market Is Screwed Up? appeared first on PeterUbel.com.
May 26, 2016
I sometimes worry that my wife Paula won’t be able to see me grow old. Not that I expect to outlive her. She is four years my junior and has the blood pressure of a 17-year-old track star. It’s her … Continue reading →
The post An Easy (But Politically Complicated) Way To Save Billions Of Dollars On Medical Care appeared first on PeterUbel.com.
May 25, 2016
There have been many wonderful new medications in the past decade or so, drugs that finally bring hope for many people with serious illnesses like rheumatoid arthritis, multiple sclerosis and even some advanced cancers. But these drugs often come at … Continue reading →
The post Specialty Drugs at Especially High Prices appeared first on PeterUbel.com.
May 17, 2016
She drew the life-saving medication into the syringe, just 10cc of colorless fluid for the everyday low price of, gulp, several hundred dollars. Was that a new chemotherapy, specially designed for her tumor? Was it a “specialty drug,” to treat … Continue reading →
The post Here’s Why Insulin Is So Expensive, And How To Reduce Its Price appeared first on PeterUbel.com.
April 29, 2016
Sometimes in my research on physician/patient communication, I come across a doctor who is so good with her patients, I have to share their bedside manner with you. The most recent example is a (to remain unnamed) oncologist in the … Continue reading →
The post Here’s How a Great Doctor Helps Her Patient Make a Cost-Conscious Treatment Decision appeared first on PeterUbel.com.
April 28, 2016
Here is a nice summary of our research, published by an excellent reporter at The American Journal of Managed Care: A new qualitative study of clinical meetings between physicians and patients pointed out certain behavioral concerns that stand in the … Continue reading →
The post More Coverage of Our Research on Out-Of-Pocket Cost Conversations appeared first on PeterUbel.com.
April 26, 2016
Aggressive control of blood pressure has saved millions of lives, and has prevented millions of people from experiencing heart attacks, strokes and kidney failure, among other things. Admittedly, controlling blood pressure is not the sexy part of medical care, but … Continue reading →
The post Physicians Can’t Stop Overtreating Diabetes And Hypertension appeared first on PeterUbel.com.
April 22, 2016
My colleagues and I have been doing lots of research lately on how physicians and patients discuss out-of-pocket expenses during clinic encounters. One of our recent publications has been getting lots of attention, with this being the latest example. I … Continue reading →
The post More Coverage of Our Out-Of-Pocket Expenses Research appeared first on PeterUbel.com.
April 18, 2016
I post pretty regularly on out-of-pocket medical expenses, a topic I’ve been conducting research on, and one that will fit centrally into the new book I’m writing. Most often when people think about paying for medical care, they think about … Continue reading →
The post The Bills People Struggle to Pay appeared first on PeterUbel.com.
April 13, 2016
With increasing frequency, Americans are purchasing health insurance plans that require high out-of-pocket costs. Chief among those costs are deductibles, the amount of money a person or family must spend out-of-pocket on medical care in a year before their health … Continue reading →
The post Inflation Crawls While Deductibles Sprint Ahead appeared first on PeterUbel.com.
View More Blog Entries
June 19, 2013 3:08 pm
Unfortunately, limited by many factors, our health-care system has suffered from insufficient experimentation and a lack of innovation in approaches to physician and nonphysician provider compensation.
May 21, 2012 4:55 pm
Think of it as a health policy wonk’s dream: Football stadium after
One insurance company’s data could fill 60 million of these. (bigstockphoto) football stadium packed to the brim with…health insurance claims data. An odd dream, to be sure. But health insurance data is crucial to understand how health care dollars get spent. It shows how people use health care, what’s changing and, in some cases, why. Health insurers, however, have tended to keep that data private, as it could tip competitors off to how they handle business.
May 20, 2012 1:37 pm
Having the results of a personalized genetic test did not drive patients to utilize potentially costly follow-up healthcare services, a study from the National Institutes of Health (NIH) found. In the past five years, there have been many new tests marketed to consumers who want to know whether they are genetically susceptible to a range of health conditions and traits, including diabetes and certain types of cancers. The tests, known as multiplex assays when they test for a variety of genetic variations, are marketed by a number of for-profit companies.
May 14, 2012 10:14 am
An Irish adage says: “When you come to a wall that is too high to climb, throw your hat over the wall, and then go get your hat.” That’s what Massachusetts started with its 2006 law requiring just about everyone to get coverage and arranging to make that coverage affordable. Now, it’s time to get the hat.
April 30, 2012 10:37 am
Worried that questioning your doctor will damage your relationship or make for an awkward office visit? Time to untie your tongue. Asking a few key questions at your next appointment could save you both money and exposure to medical risks. Meanwhile, more doctors are volunteering to help the conversation along and prescribe evidence-based conservative measures first.
April 12, 2012 11:39 pm
Spurred by patients and patient advocates like Ms. Kuhn, lawmakers in at least 20 states, from Maine to Hawaii, have introduced bills that would limit out-of-pocket payments by consumers for expensive drugs used to treat diseases like cancer,rheumatoid arthritis, multiple sclerosis and inherited disorders.
April 5, 2012 12:57 pm
The national conversation about health care reform focuses relentlessly on cost reduction. While bending the cost curve is extremely important, improving quality is also essential — but sometimes downplayed — in today’s reform equation. Grappling with quality challenges has attracted a new breed of health care leaders: physician and nurse executives.